s6y

TearLab Corp

CIK
1299139
Industry
Surgical & Medical Instruments & Apparatus
Formerly
OccuLogix, Inc.

Financials 77

  1. 10-Q/A Quarterly Report for period ending Mar 31, 2020
  2. 10-Q Quarterly Report for period ending Mar 31, 2020
  3. 10-K Annual Report for period ending Dec 31, 2019
  4. 10-Q Quarterly Report for period ending Sep 30, 2019
  5. 10-Q Quarterly Report for period ending Jun 30, 2019
  6. 10-Q Quarterly Report for period ending Mar 31, 2019
  7. 10-K Annual Report for period ending Dec 31, 2018
  8. 10-Q Quarterly Report for period ending Sep 30, 2018
  9. 10-Q Quarterly Report for period ending Jun 30, 2018
  10. 10-Q Quarterly Report for period ending Mar 31, 2018

All 77 financials filings

News 191

  1. 8-K Current report filing
  2. 8-K/A Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 191 news filings

Ownership 441

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. SC 13D/A Major Shareholders
  9. SC 13D Major Shareholders
  10. 4 Statement of changes in beneficial ownership of securities

All 441 ownership filings

Prospectus 84

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 84 prospectus filings

Proxies 43

  1. DEFM14C Definitive information statement relating to merger or acquisition
  2. PREM14C Preliminary information statements relating to merger or acquisition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. PRER14A Preliminary revised proxy soliciting materials
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 43 proxies filings

Other 91

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  3. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  4. CT ORDER Order Granting Confidential Treatment
  5. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  6. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

All 91 other filings